Le Lézard
Classified in: Health, Science and technology
Subjects: LAW, PLW

Crossmatch Settles Infringement Suit Against Integrated Biometrics


PALM BEACH GARDENS, Fla., Aug. 14, 2017 /PRNewswire/ -- Crossmatch®, a globally-recognized leader in biometric identity management and secure authentication solutions, has agreed to settle a complaint filed in the United States District Court for the District of Delaware in May 2017 against Integrated Biometrics, LLC related to alleged infringement of Crossmatch patents on fingerprint scanning technology.

Crossmatch logo

Crossmatch will grant a royalty-bearing license payable by Integrated Biometrics based on their past and future sales.

As per the settlement agreement, the parties desire to settle the litigation without the expenditure of further time and expense and are requesting that the District Court dismiss with prejudice all claims brought by Crossmatch against Integrated Biometrics.

About Crossmatch

Crossmatch® solutions solve security and identity management challenges for hundreds of millions worldwide. Our DigitalPersona® Composite Authentication solution protects enterprise using an optimal set of authentication factors, designed to meet today's unique risk requirements. Crossmatch also delivers high performing, trusted biometric identity management hardware and software for critical applications. Serving financial, retail, commercial, government, law enforcement and military markets in over 80 countries, Crossmatch sets the standard for innovation and reliability. Learn more: Crossmatch.com.

 

SOURCE Crossmatch


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: